Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 4286-4290, August 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lattime, E. C.
Right arrow Articles by McCue, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lattime, E. C.
Right arrow Articles by McCue, P. A.

Murine Bladder Carcinoma Cells Present Antigen to BCG-specific CD4+ T-Cells1

Edmund C. Lattime2, Leonard G. Gomella and Peter A. McCue

Division of Medical Oncology, Department of Medicine [E. C. L.]; and Departments of Urology [L. G. G.], and Pathology [P. A. M.], Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Intravesical administration of Bacillus Calmette-Guérin (BCG) is the most effective therapy for superficial transitional cell carcinoma of the bladder although its mechanism of action is not known. To determine if bladder tumors are capable of antigen presentation and thus might interact directly with BCG-specific T-cells, we studied the murine bladder tumor MB49. MB49 (MHC Class II negative) (IA-), when induced to express IA with interferon, presented BCG to specific CD4+ T-cells obtained from bladder-draining lymph nodes following intravesical BCG administration. This interaction resulted in antigen- and IA-dependent interleukin 2 and tumor necrosis factor production. Interferon also induced MB49 IA expression in vivo. This first demonstration of antigen presentation by epithelial tumors supports new approaches to immunotherapy of these malignancies.

1 Supported by USPHS Grant CA-42908.

2 To whom requests for reprints should be addressed, at Thomas Jefferson University, Division of Medical Oncology, 7015 Walnut St. Suite 1005, Philadelphia, PA 19107.

Received 3/30/92. Accepted 6/15/92.




This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
J-P Meyer, R Persad, and D A Gillatt
Use of bacille Calmette-Guerin in superficial bladder cancer
Postgrad. Med. J., August 1, 2002; 78(922): 449 - 454.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. P. Lavelle, G. Apodaca, S. A. Meyers, W. G. Ruiz, and M. L. Zeidel
Disruption of guinea pig urinary bladder permeability barrier in noninfectious cystitis
Am J Physiol Renal Physiol, January 1, 1998; 274(1): F205 - F214.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.